RxDoctor Payments Data

Debra Martin

Family · Littleton, CONPI 1518344167

Payments from drug & device makers

$394in general payments, 2019–2025

Across 21 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$71
  • Novartis$49
  • AbbVie$48
  • AstraZeneca$43
  • Lilly USA, LLC$30
  • Novo Nordisk$29
  • plus $124 from 7 others

What the payments were for

  • Food & beverage$394100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$394 in reported general payments places this provider in the 60th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$54,010
Medicare patients
87
Services billed
507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$25,119
EliquisApixaban34$24,582
XareltoRivaroxaban32$17,867
JardianceEmpagliflozin13$7,991
JanumetSitagliptin Phos/Metformin Hcl12$6,762
Diclofenac Sodium47$1,836
Atorvastatin Calcium111$932
Metoprolol Succinate53$707
Gabapentin66$696
Lidocaine11$622
Levothyroxine Sodium113$611
Omeprazole67$547
Potassium Chloride42$480
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide16$466
Levetiracetam18$407

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$29$25,11925 claims
PfizerEliquis$71$24,58234 claims
Johnson & JohnsonXarelto$14$17,86732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,182 family providers in Colorado.

Other family in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →